Last reviewed · How we verify
Experimental: essential oils and ELA
Essential oils combined with ELA (likely a proprietary extract or formulation) work through antimicrobial and anti-inflammatory properties to address unspecified therapeutic targets.
At a glance
| Generic name | Experimental: essential oils and ELA |
|---|---|
| Also known as | Listerine Professional Gum Therapy®, Johnson & Johnson,USA |
| Sponsor | University of Oslo |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Essential oils contain volatile compounds with documented antimicrobial and anti-inflammatory activity. The specific mechanism of ELA and its synergy with essential oils is not publicly characterized in standard pharmaceutical databases. Without published clinical data, the precise molecular targets and therapeutic pathway remain unclear.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Experimental: essential oils and ELA CI brief — competitive landscape report
- Experimental: essential oils and ELA updates RSS · CI watch RSS
- University of Oslo portfolio CI